Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.93444093 |
2 | regulation of guanylate cyclase activity (GO:0031282) | 7.71146812 |
3 | NADH metabolic process (GO:0006734) | 7.03707303 |
4 | regulation of cellular extravasation (GO:0002691) | 6.85432220 |
5 | intestinal absorption (GO:0050892) | 6.19484075 |
6 | lipoprotein transport (GO:0042953) | 6.18352295 |
7 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.99049634 |
8 | regulation of bile acid biosynthetic process (GO:0070857) | 5.82629097 |
9 | epoxygenase P450 pathway (GO:0019373) | 5.63887265 |
10 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.63119309 |
11 | fructose metabolic process (GO:0006000) | 5.57095775 |
12 | positive regulation of pseudopodium assembly (GO:0031274) | 5.29086095 |
13 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.99977419 |
14 | endocrine process (GO:0050886) | 4.99977419 |
15 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.99977419 |
16 | hormone catabolic process (GO:0042447) | 4.93964704 |
17 | regulation of pseudopodium assembly (GO:0031272) | 4.75741298 |
18 | adhesion of symbiont to host cell (GO:0044650) | 4.73260619 |
19 | virion attachment to host cell (GO:0019062) | 4.73260619 |
20 | regulation of cGMP biosynthetic process (GO:0030826) | 4.70278561 |
21 | diacylglycerol metabolic process (GO:0046339) | 4.63504047 |
22 | regulation of systemic arterial blood pressure (GO:0003073) | 4.60714351 |
23 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.57076757 |
24 | urea cycle (GO:0000050) | 4.46628915 |
25 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.44647338 |
26 | * antibacterial humoral response (GO:0019731) | 4.33539270 |
27 | peptide catabolic process (GO:0043171) | 4.31881443 |
28 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.30426111 |
29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.30403522 |
30 | peptide hormone processing (GO:0016486) | 4.27328331 |
31 | * antimicrobial humoral response (GO:0019730) | 4.24395438 |
32 | urea metabolic process (GO:0019627) | 4.22803690 |
33 | drug metabolic process (GO:0017144) | 4.17744444 |
34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.14538288 |
35 | positive regulation of glycoprotein metabolic process (GO:1903020) | 4.12572468 |
36 | regulation of vitamin metabolic process (GO:0030656) | 4.09228489 |
37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.05589244 |
38 | vitamin A metabolic process (GO:0006776) | 4.05380449 |
39 | positive regulation of respiratory burst (GO:0060267) | 4.02877939 |
40 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.01808452 |
41 | adhesion of symbiont to host (GO:0044406) | 3.99456644 |
42 | glycolipid catabolic process (GO:0019377) | 3.97909998 |
43 | nitrogen cycle metabolic process (GO:0071941) | 3.95364175 |
44 | glycosphingolipid catabolic process (GO:0046479) | 3.93669554 |
45 | digestion (GO:0007586) | 3.91724405 |
46 | regulation of cGMP metabolic process (GO:0030823) | 3.90649043 |
47 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.88571385 |
48 | regulation of triglyceride catabolic process (GO:0010896) | 3.85515287 |
49 | bile acid and bile salt transport (GO:0015721) | 3.85434489 |
50 | renal system process involved in regulation of blood volume (GO:0001977) | 3.79077762 |
51 | plasma lipoprotein particle assembly (GO:0034377) | 3.75832830 |
52 | response to nitric oxide (GO:0071731) | 3.74307691 |
53 | arginine metabolic process (GO:0006525) | 3.67771543 |
54 | glucuronate metabolic process (GO:0019585) | 3.62754918 |
55 | uronic acid metabolic process (GO:0006063) | 3.62754918 |
56 | cellular glucuronidation (GO:0052695) | 3.60626949 |
57 | cellular response to nitric oxide (GO:0071732) | 3.57879161 |
58 | alkaloid metabolic process (GO:0009820) | 3.48926331 |
59 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.48393160 |
60 | protein-lipid complex assembly (GO:0065005) | 3.42460431 |
61 | lipoprotein metabolic process (GO:0042157) | 3.41864077 |
62 | vitamin transmembrane transport (GO:0035461) | 3.41804581 |
63 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.34638122 |
64 | glomerular filtration (GO:0003094) | 3.33038485 |
65 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.30994882 |
66 | eosinophil chemotaxis (GO:0048245) | 3.30078545 |
67 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.28993774 |
68 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.28648088 |
69 | midgut development (GO:0007494) | 3.26596497 |
70 | homocysteine metabolic process (GO:0050667) | 3.26464078 |
71 | vitamin transport (GO:0051180) | 3.25252920 |
72 | drinking behavior (GO:0042756) | 3.23423539 |
73 | complement activation, classical pathway (GO:0006958) | 3.22334723 |
74 | cGMP-mediated signaling (GO:0019934) | 3.20518395 |
75 | low-density lipoprotein particle remodeling (GO:0034374) | 3.17870946 |
76 | ceramide catabolic process (GO:0046514) | 3.16057621 |
77 | cellular response to reactive nitrogen species (GO:1902170) | 3.14978517 |
78 | positive regulation of antigen processing and presentation (GO:0002579) | 3.13335067 |
79 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.13110758 |
80 | sexual reproduction (GO:0019953) | 3.11917888 |
81 | transcytosis (GO:0045056) | 3.10763022 |
82 | fat-soluble vitamin metabolic process (GO:0006775) | 3.08970250 |
83 | digestive system process (GO:0022600) | 3.08129937 |
84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.07960314 |
85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.07960314 |
86 | drug catabolic process (GO:0042737) | 3.07646808 |
87 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.07604346 |
88 | positive regulation of cGMP metabolic process (GO:0030825) | 3.02799328 |
89 | renal filtration (GO:0097205) | 3.02266009 |
90 | regulation of cholesterol homeostasis (GO:2000188) | 3.02187818 |
91 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.01256652 |
92 | mRNA modification (GO:0016556) | 3.00873083 |
93 | actin filament depolymerization (GO:0030042) | 2.98056604 |
94 | flavonoid metabolic process (GO:0009812) | 2.97576053 |
95 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.97218282 |
96 | phospholipid efflux (GO:0033700) | 2.96908087 |
97 | sphingolipid catabolic process (GO:0030149) | 2.96085343 |
98 | cyclooxygenase pathway (GO:0019371) | 2.95770071 |
99 | glycosylceramide metabolic process (GO:0006677) | 2.95678064 |
100 | angiotensin maturation (GO:0002003) | 10.6402468 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.84561666 |
2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.71382909 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.73330450 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.62074005 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.53908019 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.99724720 |
7 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.88673391 |
8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.85047003 |
9 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.79892053 |
10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.51329414 |
11 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.39938743 |
12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.39180827 |
13 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.33194506 |
14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.28371304 |
15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.14022317 |
16 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.12374506 |
17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.12293360 |
18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.10067812 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.96037740 |
20 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.94692562 |
21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.93916286 |
22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.91304464 |
23 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.88936217 |
24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88693699 |
25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.87462344 |
26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.85242850 |
27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.78581492 |
28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.77360655 |
29 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.71122381 |
30 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.61845437 |
31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53318639 |
32 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.51430343 |
33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38542335 |
34 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37527725 |
35 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36786153 |
36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33825889 |
37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.33677808 |
38 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.30932802 |
39 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30555823 |
40 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.29662057 |
41 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28841557 |
42 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27306795 |
43 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.26815973 |
44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.25477402 |
45 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24958047 |
46 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.24051074 |
47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23937793 |
48 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23693107 |
49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20597980 |
50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17538802 |
51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16579628 |
52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15908617 |
53 | GATA2_19941826_ChIP-Seq_K562_Human | 1.14926937 |
54 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13830708 |
55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13136311 |
56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11521097 |
57 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11079494 |
58 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09247521 |
59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09056516 |
60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08784832 |
61 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.06958665 |
62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06052359 |
63 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05906260 |
64 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04931814 |
65 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.04455036 |
66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03295678 |
67 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02267187 |
68 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00999991 |
69 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98227383 |
70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98116878 |
71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97339901 |
72 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.95959527 |
73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95866763 |
74 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93605550 |
75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92818736 |
76 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92078981 |
77 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91936052 |
78 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.91643401 |
79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91639965 |
80 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91596147 |
81 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91132147 |
82 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90579540 |
83 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90032455 |
84 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89254615 |
85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87684686 |
86 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86949741 |
87 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.86170812 |
88 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.85779175 |
89 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84922919 |
90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84798747 |
91 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84631539 |
92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82259736 |
93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81656053 |
94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81482436 |
95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.80627263 |
96 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.79614206 |
97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79114611 |
98 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.78835483 |
99 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78066732 |
100 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.77868308 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 8.44384370 |
2 | MP0001666_abnormal_nutrient_absorption | 4.58909553 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.17134784 |
4 | MP0009379_abnormal_foot_pigmentation | 3.96281003 |
5 | MP0003183_abnormal_peptide_metabolism | 3.96165844 |
6 | MP0002139_abnormal_hepatobiliary_system | 3.72116237 |
7 | MP0004019_abnormal_vitamin_homeostasis | 3.40320797 |
8 | MP0010155_abnormal_intestine_physiology | 3.29469385 |
9 | MP0005365_abnormal_bile_salt | 3.17543388 |
10 | MP0009840_abnormal_foam_cell | 3.12879801 |
11 | MP0004264_abnormal_extraembryonic_tissu | 2.93618940 |
12 | MP0004147_increased_porphyrin_level | 2.89499925 |
13 | MP0010234_abnormal_vibrissa_follicle | 2.80833799 |
14 | MP0003866_abnormal_defecation | 2.17515370 |
15 | MP0005409_darkened_coat_color | 2.13053155 |
16 | MP0001664_abnormal_digestion | 2.01950900 |
17 | MP0000490_abnormal_crypts_of | 1.99483267 |
18 | MP0010352_gastrointestinal_tract_polyps | 1.92952323 |
19 | MP0004858_abnormal_nervous_system | 1.91625422 |
20 | MP0010329_abnormal_lipoprotein_level | 1.88780268 |
21 | MP0005166_decreased_susceptibility_to | 1.81897903 |
22 | MP0001873_stomach_inflammation | 1.78690767 |
23 | MP0009643_abnormal_urine_homeostasis | 1.71529975 |
24 | MP0005332_abnormal_amino_acid | 1.71404703 |
25 | MP0000477_abnormal_intestine_morphology | 1.56005885 |
26 | MP0000678_abnormal_parathyroid_gland | 1.52799530 |
27 | MP0003868_abnormal_feces_composition | 1.52459626 |
28 | MP0004782_abnormal_surfactant_physiolog | 1.47427308 |
29 | MP0000538_abnormal_urinary_bladder | 1.45303181 |
30 | MP0001764_abnormal_homeostasis | 1.45239860 |
31 | MP0003806_abnormal_nucleotide_metabolis | 1.45042231 |
32 | MP0002876_abnormal_thyroid_physiology | 1.43071586 |
33 | MP0003252_abnormal_bile_duct | 1.41260636 |
34 | MP0001663_abnormal_digestive_system | 1.40086495 |
35 | MP0001188_hyperpigmentation | 1.34718200 |
36 | MP0001765_abnormal_ion_homeostasis | 1.28487491 |
37 | MP0001835_abnormal_antigen_presentation | 1.19069736 |
38 | MP0000462_abnormal_digestive_system | 1.18083201 |
39 | MP0003724_increased_susceptibility_to | 1.17550831 |
40 | MP0002822_catalepsy | 1.17449732 |
41 | MP0002136_abnormal_kidney_physiology | 1.17424544 |
42 | MP0005381_digestive/alimentary_phenotyp | 1.15156670 |
43 | MP0001845_abnormal_inflammatory_respons | 1.12029048 |
44 | MP0001501_abnormal_sleep_pattern | 1.11871599 |
45 | MP0003879_abnormal_hair_cell | 1.10895865 |
46 | MP0005636_abnormal_mineral_homeostasis | 1.10424440 |
47 | MP0002118_abnormal_lipid_homeostasis | 1.07221420 |
48 | MP0005451_abnormal_body_composition | 1.06268634 |
49 | MP0003718_maternal_effect | 1.05606516 |
50 | MP0009785_altered_susceptibility_to | 1.04651076 |
51 | MP0001790_abnormal_immune_system | 1.04611293 |
52 | MP0005387_immune_system_phenotype | 1.04611293 |
53 | MP0003436_decreased_susceptibility_to | 1.04275522 |
54 | MP0002166_altered_tumor_susceptibility | 1.02430666 |
55 | MP0004270_analgesia | 1.01807495 |
56 | MP0000465_gastrointestinal_hemorrhage | 1.00474036 |
57 | MP0005670_abnormal_white_adipose | 0.98366729 |
58 | MP0005025_abnormal_response_to | 0.97861017 |
59 | MP0003300_gastrointestinal_ulcer | 0.97809285 |
60 | MP0005448_abnormal_energy_balance | 0.97691526 |
61 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96370406 |
62 | MP0001756_abnormal_urination | 0.95486621 |
63 | MP0005535_abnormal_body_temperature | 0.93736487 |
64 | MP0003329_amyloid_beta_deposits | 0.92799894 |
65 | MP0000609_abnormal_liver_physiology | 0.90247675 |
66 | MP0003191_abnormal_cellular_cholesterol | 0.89069061 |
67 | MP0002138_abnormal_hepatobiliary_system | 0.88918646 |
68 | MP0003303_peritoneal_inflammation | 0.88377452 |
69 | MP0002796_impaired_skin_barrier | 0.87576646 |
70 | MP0002971_abnormal_brown_adipose | 0.87439723 |
71 | MP0000604_amyloidosis | 0.87113627 |
72 | MP0005671_abnormal_response_to | 0.84355796 |
73 | MP0008469_abnormal_protein_level | 0.81182010 |
74 | MP0000537_abnormal_urethra_morphology | 0.80524920 |
75 | MP0006082_CNS_inflammation | 0.78815065 |
76 | MP0002098_abnormal_vibrissa_morphology | 0.77643047 |
77 | MP0009115_abnormal_fat_cell | 0.73983620 |
78 | MP0009764_decreased_sensitivity_to | 0.73824106 |
79 | MP0000230_abnormal_systemic_arterial | 0.72435078 |
80 | MP0005319_abnormal_enzyme/_coenzyme | 0.72036839 |
81 | MP0000685_abnormal_immune_system | 0.71230620 |
82 | MP0004947_skin_inflammation | 0.70092663 |
83 | MP0009333_abnormal_splenocyte_physiolog | 0.69576926 |
84 | MP0001485_abnormal_pinna_reflex | 0.68882279 |
85 | MP0004043_abnormal_pH_regulation | 0.67998079 |
86 | MP0002148_abnormal_hypersensitivity_rea | 0.66846076 |
87 | MP0000249_abnormal_blood_vessel | 0.66605518 |
88 | MP0001533_abnormal_skeleton_physiology | 0.66591053 |
89 | MP0001800_abnormal_humoral_immune | 0.65502549 |
90 | MP0009642_abnormal_blood_homeostasis | 0.64147584 |
91 | MP0002396_abnormal_hematopoietic_system | 0.64021726 |
92 | MP0002006_tumorigenesis | 0.63166530 |
93 | MP0008004_abnormal_stomach_pH | 0.62829226 |
94 | MP0002896_abnormal_bone_mineralization | 0.62760839 |
95 | MP0001881_abnormal_mammary_gland | 0.59794773 |
96 | MP0005058_abnormal_lysosome_morphology | 0.59390046 |
97 | MP0005000_abnormal_immune_tolerance | 0.57460827 |
98 | MP0005310_abnormal_salivary_gland | 0.57202410 |
99 | MP0005666_abnormal_adipose_tissue | 0.54530141 |
100 | MP0005165_increased_susceptibility_to | 0.54462101 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Malnutrition (HP:0004395) | 7.51434188 |
2 | Abnormality of proline metabolism (HP:0010907) | 6.63218441 |
3 | Hydroxyprolinuria (HP:0003080) | 6.63218441 |
4 | Chronic diarrhea (HP:0002028) | 5.50237261 |
5 | Systemic lupus erythematosus (HP:0002725) | 5.41637281 |
6 | Hypobetalipoproteinemia (HP:0003563) | 4.93568103 |
7 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.88915753 |
8 | Ileus (HP:0002595) | 4.72554434 |
9 | Abnormality of vitamin B metabolism (HP:0004340) | 4.56131814 |
10 | Fat malabsorption (HP:0002630) | 4.34389511 |
11 | Widely patent fontanelles and sutures (HP:0004492) | 4.24414821 |
12 | Acanthocytosis (HP:0001927) | 4.12820416 |
13 | Confusion (HP:0001289) | 3.98472873 |
14 | Nausea (HP:0002018) | 3.80396864 |
15 | Abnormality of vitamin metabolism (HP:0100508) | 3.58944359 |
16 | Pigmentary retinal degeneration (HP:0001146) | 3.55711305 |
17 | Glycosuria (HP:0003076) | 3.45598798 |
18 | Abnormality of urine glucose concentration (HP:0011016) | 3.45598798 |
19 | Proximal tubulopathy (HP:0000114) | 3.39151120 |
20 | Thin bony cortex (HP:0002753) | 3.33497446 |
21 | Hyperglycinuria (HP:0003108) | 3.32585541 |
22 | Congenital sensorineural hearing impairment (HP:0008527) | 3.24130138 |
23 | Eczematoid dermatitis (HP:0000976) | 3.22623119 |
24 | Wide cranial sutures (HP:0010537) | 3.21403599 |
25 | Decreased circulating renin level (HP:0003351) | 3.17126753 |
26 | Nephrolithiasis (HP:0000787) | 3.05309544 |
27 | Alkalosis (HP:0001948) | 3.01042162 |
28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.97687293 |
29 | Glomerulonephritis (HP:0000099) | 2.96249161 |
30 | Xanthomatosis (HP:0000991) | 2.93979892 |
31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.92841829 |
32 | Abnormality of glycine metabolism (HP:0010895) | 2.92841829 |
33 | Hypophosphatemia (HP:0002148) | 2.91673747 |
34 | Metabolic alkalosis (HP:0200114) | 2.91065388 |
35 | Increased purine levels (HP:0004368) | 2.89945029 |
36 | Hyperuricemia (HP:0002149) | 2.89945029 |
37 | Abdominal distention (HP:0003270) | 2.88494223 |
38 | Steatorrhea (HP:0002570) | 2.83462002 |
39 | Abnormality of complement system (HP:0005339) | 2.82031362 |
40 | Posterior subcapsular cataract (HP:0007787) | 2.79470863 |
41 | Hyperparathyroidism (HP:0000843) | 2.78042309 |
42 | Facial shape deformation (HP:0011334) | 2.77510752 |
43 | Potter facies (HP:0002009) | 2.77510752 |
44 | Villous atrophy (HP:0011473) | 2.76226687 |
45 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.76226687 |
46 | Complement deficiency (HP:0004431) | 2.68784015 |
47 | Hyperammonemia (HP:0001987) | 2.61337110 |
48 | Hyperactive renin-angiotensin system (HP:0000841) | 2.58724199 |
49 | Megaloblastic anemia (HP:0001889) | 2.53695582 |
50 | Nephritis (HP:0000123) | 2.50761159 |
51 | Abnormality of purine metabolism (HP:0004352) | 2.48505098 |
52 | Hemorrhage of the eye (HP:0011885) | 2.48192725 |
53 | Abnormality of renin-angiotensin system (HP:0000847) | 2.37713649 |
54 | Hypotension (HP:0002615) | 2.36256658 |
55 | Abnormal urine phosphate concentration (HP:0012599) | 2.34404270 |
56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.34103406 |
57 | Hypolipoproteinemia (HP:0010981) | 2.32590236 |
58 | Abnormality of nucleobase metabolism (HP:0010932) | 2.30824140 |
59 | Enlarged epiphyses (HP:0010580) | 2.30203894 |
60 | Cerebral palsy (HP:0100021) | 2.26268386 |
61 | Hyperphosphaturia (HP:0003109) | 2.26212810 |
62 | Pancreatitis (HP:0001733) | 2.23928620 |
63 | Hyperphosphatemia (HP:0002905) | 2.23559938 |
64 | Focal segmental glomerulosclerosis (HP:0000097) | 2.22848855 |
65 | Gingivitis (HP:0000230) | 2.20934391 |
66 | Abnormal glucose tolerance (HP:0001952) | 2.18415286 |
67 | Delayed epiphyseal ossification (HP:0002663) | 2.17015252 |
68 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13217212 |
69 | Dicarboxylic aciduria (HP:0003215) | 2.13217212 |
70 | Gastrointestinal dysmotility (HP:0002579) | 2.07830888 |
71 | Growth hormone excess (HP:0000845) | 2.06146317 |
72 | Abnormality of the costochondral junction (HP:0000919) | 2.04639917 |
73 | Metabolic acidosis (HP:0001942) | 2.02414309 |
74 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 10.0382897 |
75 | Protuberant abdomen (HP:0001538) | 1.99832116 |
76 | Subcapsular cataract (HP:0000523) | 1.99119476 |
77 | Right ventricular cardiomyopathy (HP:0011663) | 1.97697351 |
78 | Epidermoid cyst (HP:0200040) | 1.96002982 |
79 | Gastrointestinal stroma tumor (HP:0100723) | 1.95398054 |
80 | Renal tubular acidosis (HP:0001947) | 1.94013087 |
81 | Gout (HP:0001997) | 1.93674310 |
82 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.92247504 |
83 | Abnormality of magnesium homeostasis (HP:0004921) | 1.87148455 |
84 | Irritability (HP:0000737) | 1.85334693 |
85 | Emphysema (HP:0002097) | 1.84852342 |
86 | Multiple lipomas (HP:0001012) | 1.84465378 |
87 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.77081925 |
88 | Paresthesia (HP:0003401) | 1.75543074 |
89 | Hypoalbuminemia (HP:0003073) | 1.75472767 |
90 | Abnormal albumin level (HP:0012116) | 1.75472767 |
91 | Skin rash (HP:0000988) | 1.75249666 |
92 | Poikilocytosis (HP:0004447) | 1.74138357 |
93 | Symptomatic seizures (HP:0011145) | 1.73829559 |
94 | Hypocalcemia (HP:0002901) | 1.72636999 |
95 | Petechiae (HP:0000967) | 1.71279926 |
96 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.70932145 |
97 | Pili torti (HP:0003777) | 1.70543515 |
98 | Bone pain (HP:0002653) | 1.69285522 |
99 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.68985020 |
100 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.68782457 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 7.16419528 |
2 | ERN1 | 5.15219441 |
3 | MST1R | 4.24946722 |
4 | PRKG2 | 3.44763679 |
5 | RIPK1 | 3.40991838 |
6 | MAP3K10 | 2.97346341 |
7 | FGFR4 | 2.57582949 |
8 | EPHA2 | 2.46463022 |
9 | TYK2 | 2.24627293 |
10 | STK39 | 2.14337572 |
11 | EPHA3 | 2.04691444 |
12 | EPHB2 | 1.97668533 |
13 | TESK2 | 1.92520448 |
14 | MAP4K1 | 1.87612610 |
15 | OXSR1 | 1.85011405 |
16 | PTK6 | 1.76009358 |
17 | EPHB1 | 1.63241355 |
18 | MAP3K12 | 1.47234756 |
19 | MET | 1.46575920 |
20 | GRK6 | 1.46525008 |
21 | DDR2 | 1.46270567 |
22 | PRPF4B | 1.39027085 |
23 | RIPK4 | 1.35805782 |
24 | MAP3K2 | 1.35519444 |
25 | PDK2 | 1.31278783 |
26 | MAP3K1 | 1.28930468 |
27 | FGFR3 | 1.27788071 |
28 | MATK | 1.22978137 |
29 | MYLK | 1.22584923 |
30 | MAP2K2 | 1.19675853 |
31 | CDC42BPA | 1.13845962 |
32 | STK24 | 1.09356121 |
33 | TESK1 | 1.07904289 |
34 | TNIK | 1.06079399 |
35 | MAP3K11 | 1.00123782 |
36 | NLK | 0.99421177 |
37 | MST4 | 0.85257441 |
38 | ERBB2 | 0.85224701 |
39 | JAK1 | 0.84802133 |
40 | EPHA4 | 0.83322836 |
41 | PDPK1 | 0.83095178 |
42 | PIK3CA | 0.82421010 |
43 | TBK1 | 0.81870779 |
44 | TAOK1 | 0.80169792 |
45 | IKBKE | 0.79216507 |
46 | CDK19 | 0.74628328 |
47 | AKT3 | 0.72970660 |
48 | IRAK1 | 0.71782077 |
49 | FER | 0.70689590 |
50 | JAK3 | 0.69104148 |
51 | MAPK11 | 0.67004316 |
52 | PRKACG | 0.65055845 |
53 | ZAP70 | 0.64341492 |
54 | CSK | 0.61805211 |
55 | MAP2K6 | 0.61606732 |
56 | DYRK1B | 0.61167967 |
57 | JAK2 | 0.60676180 |
58 | LMTK2 | 0.60518866 |
59 | BMPR2 | 0.59099267 |
60 | KIT | 0.58133116 |
61 | PDK1 | 0.57568127 |
62 | PRKCZ | 0.57113239 |
63 | PRKCA | 0.54949174 |
64 | TRIB3 | 0.54775049 |
65 | PRKAA2 | 0.53693599 |
66 | PDGFRA | 0.53081030 |
67 | BMX | 0.52278535 |
68 | CSF1R | 0.50678301 |
69 | KSR2 | 0.49983322 |
70 | MAP3K14 | 0.49733529 |
71 | RET | 0.49440297 |
72 | SRC | 0.48722555 |
73 | SMG1 | 0.46995351 |
74 | PIM1 | 0.46888324 |
75 | BTK | 0.46880024 |
76 | SYK | 0.45790916 |
77 | FYN | 0.45668182 |
78 | PAK4 | 0.43152445 |
79 | ITK | 0.41416596 |
80 | CAMK2D | 0.39361762 |
81 | ABL2 | 0.39286055 |
82 | YES1 | 0.38901676 |
83 | CASK | 0.38047017 |
84 | TGFBR2 | 0.37825019 |
85 | CDK6 | 0.37712653 |
86 | IRAK4 | 0.37507918 |
87 | PRKCD | 0.36818730 |
88 | PTK2 | 0.36014680 |
89 | LYN | 0.35192680 |
90 | MAP3K3 | 0.34815810 |
91 | KDR | 0.33882453 |
92 | LCK | 0.33331905 |
93 | CAMK2G | 0.33320893 |
94 | DMPK | 0.31031191 |
95 | CAMK2B | 0.27597178 |
96 | TEC | 0.27127536 |
97 | MAPKAPK2 | 0.25381279 |
98 | MAP3K8 | 0.25039770 |
99 | BLK | 0.23175732 |
100 | LRRK2 | 0.22404209 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.32767720 |
2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.57218847 |
3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 4.18906642 |
4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.95116943 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48521274 |
6 | Mineral absorption_Homo sapiens_hsa04978 | 2.47239390 |
7 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.42990245 |
8 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.25362174 |
9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.17661625 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.12972218 |
11 | Asthma_Homo sapiens_hsa05310 | 2.01336545 |
12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.00712759 |
13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.98615249 |
14 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.97065532 |
15 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.83488556 |
16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.75815948 |
17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.74216316 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.74032215 |
19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.73410768 |
20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71891496 |
21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.68159642 |
22 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.66221816 |
23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65547160 |
24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58024420 |
25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.54337798 |
26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53531876 |
27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51566822 |
28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.50109902 |
29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.48852470 |
30 | Allograft rejection_Homo sapiens_hsa05330 | 1.47324002 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.43663191 |
32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38837759 |
33 | Bile secretion_Homo sapiens_hsa04976 | 1.37008338 |
34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.32490419 |
35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.31784983 |
36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.30232050 |
37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.28760990 |
38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.19892906 |
39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17751352 |
40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.13826265 |
41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.11818037 |
42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09186887 |
43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07941439 |
44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.99997219 |
45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99572716 |
46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91091178 |
47 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87021879 |
48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83122963 |
49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81762761 |
50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79071326 |
51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77743504 |
52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76960803 |
53 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75964125 |
54 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71986244 |
55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69508721 |
56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67472456 |
57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57542940 |
58 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56586746 |
59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56492103 |
60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56155884 |
61 | Pertussis_Homo sapiens_hsa05133 | 0.46753104 |
62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43460546 |
63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41645477 |
64 | Peroxisome_Homo sapiens_hsa04146 | 0.40308743 |
65 | Renin secretion_Homo sapiens_hsa04924 | 0.39692074 |
66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39260086 |
67 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36561954 |
68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35230967 |
69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35171566 |
70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34250994 |
71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30782079 |
72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29676741 |
73 | Hepatitis C_Homo sapiens_hsa05160 | 0.28780776 |
74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28090993 |
75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27921099 |
76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.27740267 |
77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27226742 |
78 | Insulin resistance_Homo sapiens_hsa04931 | 0.26542343 |
79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24019249 |
80 | Tuberculosis_Homo sapiens_hsa05152 | 0.22583125 |
81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20384279 |
82 | Influenza A_Homo sapiens_hsa05164 | 0.19502286 |
83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.18100136 |
84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.17978614 |
85 | Cocaine addiction_Homo sapiens_hsa05030 | 0.15711582 |
86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.15090613 |
87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.14432258 |
88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12780904 |
89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.12748344 |
90 | ABC transporters_Homo sapiens_hsa02010 | 0.11944373 |
91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.10682377 |
92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.09986547 |
93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.09843760 |
94 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.09411767 |
95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.08219887 |
96 | Tight junction_Homo sapiens_hsa04530 | 0.05531261 |
97 | Insulin secretion_Homo sapiens_hsa04911 | 0.05257560 |
98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05180379 |
99 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.04541100 |
100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.03875885 |